Sr. Director, Global Brand & Portfolio Management

About the Role

The Sr. Director, Global Brand & Portfolio Management is accountable for defining and executing Seqirus's global portfolio vision and strategy across current influenza brands (inline), pipeline assets, and adjacent vaccine opportunities. This role leads a team responsible for global product portfolio strategy and positioning, global brand and lifecycle management, and new product planning and launch readiness.

In partnership with cross-functional stakeholders, the role provides commercial and portfolio leadership to inform evidence generation priorities, pricing and market access strategies, and portfolio investments. Working in close partnership with R&D and cross-functional stakeholders, the role ensures alignment from research through commercialization, advances high-value strategic investments, and drives portfolio decisions that maximize mid- to long-term growth, value creation, and public health impact. As a member of the Global Commercial Strategy & Planning (GCS&P) Leadership Team, the Sr. Director serves as a key strategic leader across the global vaccines organization. This is a hybrid role, combining onsite and remote work.

Responsibilities

• Lead the development and execution of Seqirus's global Portfolio Development Strategy (PDS) in partnership with R&D and GCS&P’s External Partnerships team, ensuring alignment with the broader Business Unit (BU) Strategy.
• Partner with GCS&P’s Strategy & Business Planning team on the development and evolution of the BU Strategy, including overseeing strategic imperatives, objectives, and cross-functional tactical plans.
• Direct a team responsible for global product strategy across marketed vaccines, pipeline assets, and launch products.
• Define product portfolio positioning, co-positioning strategies, above-brand narratives, evidence themes, lifecycle priorities, and portfolio investment recommendations.
• Oversee lifecycle management strategies that drive both short- and long-term growth of commercialized brands.
• Lead global launch planning and commercialization readiness for pipeline assets, including launch sequencing, business case development, and resource prioritization.
• Oversee and guide continued global launch planning for aTIVc, including maximizing the portfolio opportunity across Fluad and aTIVc, refining the launch sequencing strategy, advancing business cases for key investments, and leveraging the Glocal brand marketing model.
• Direct geographic expansion strategies and evaluate market entry and exit opportunities across the portfolio.
• Provide portfolio and commercial input into long-term pricing strategies, value propositions, and market access planning in partnership with Global Market Access & Pricing for both inline and pipeline products.
• Support evaluation of external partnerships, business development opportunities, and portfolio expansion opportunities led by GCS&P’s External Partnerships team.
• Oversee development and continuous improvement of global claims, messaging, communications, and scientific narratives.
• Ensure product portfolio strategies are informed by market research, competitive intelligence, customer insights, epidemiological trends, and evolving vaccine market dynamics.
• Manage team budgets and identify opportunities to improve operational efficiency and return on investment.
• Lead the commercial evaluation and strategic development of internal vaccine programs from early development through commercialization in partnership with R&D and cross-functional teams.
• Direct assessment of key development milestones, including clinical strategy, evidence requirements, comparator selection, timing, and commercial readiness.
• Identify portfolio opportunities, risks, data gaps, and investment priorities; guide cross-functional teams in developing plans to address them.
• Support and/or lead governance processes and planning forums to ensure timely decision-making, transparency, accountability, and strategic alignment.
• Uphold portfolio-level decision frameworks, escalation pathways, and implementation roadmaps for strategic priorities.
• Develop and advance business cases for major internal product investments, clinical development programs, and portfolio expansion opportunities.
• Influence senior leadership on prioritization, resource allocation, funding decisions, and long-range investment strategies.
• Represent the commercial function in governance forums and ensure Seqirus business unit priorities are reflected in CSL enterprise strategic decisions.
• Oversee or lead cross-functional and global brand team governance across commercial, R&D, CEA, finance, operations, supply chain, and external partnerships.
• Align regional and functional strategies with overall portfolio objectives and resolve competing priorities across brands and functions.
• Lead strategic discussions with global and regional commercial leaders to advance lifecycle opportunities and pipeline development plans.
• Foster collaboration across regions to ensure consistent execution of portfolio strategies while addressing market-specific needs.
• Optimize portfolio investment allocation and resource prioritization to maximize mid- to long-term portfolio value and return on investment.
• Integrate evidence generation, publication planning, and scientific communication strategies to support a unified portfolio narrative.
• Lead scenario planning, competitive assessments, and risk mitigation efforts across the portfolio.
• Establish strong partnerships with external agencies, consultants, industry organizations, and key strategic partners.
• Lead or support strategic initiatives and assessments related to the evolving global vaccine landscape, including:
  • Evaluation of changing market dynamics and competitive threats.
  • Development of commercialization and defense strategies for emerging technologies and combination products.
  • Partnering with CEA to assess policy, immunization guidelines, and governmental changes impacting portfolio growth.
  • Strategic evaluation of adjacent vaccine opportunities and business development investments.
  • Advancement of high-priority business cases supporting portfolio expansion and mid- to long-term growth.

Qualifications

• Minimum 12 years of experience in the pharmaceutical industry, including at least 8 years in commercial, sales, or marketing (vaccines experience highly preferred).
• 5+ years in portfolio strategy or multi-brand leadership.
• Minimum 7 years of experience managing personnel, project management, and leading cross-functional global teams.
• Proven success in growing established products, particularly across global markets.
• Bachelor of Science; MBA or MS (Pharmaceutical or basic sciences) preferred.

Skills

• Executive leadership and change leadership capabilities.
• Strong strategic thinking, business acumen, and portfolio management expertise.
• Systems-thinking mindset with the ability to connect brand strategies to portfolio outcomes.
• Deep understanding of pharmaceutical and vaccine commercialization, lifecycle management, and product development.
• Demonstrated expertise in strategic planning, governance design, investment prioritization, and resource allocation.
• Strong financial acumen and business case development skills.
• Data-driven decision-making utilizing clinical, real-world evidence (RWE), HEOR, market, and competitive insights.
• Exceptional stakeholder management and influence skills, including the ability to lead without direct authority.
• Outstanding communication, presentation, and executive engagement capabilities.
• Proven success leading cross-functional global teams and building alignment across diverse stakeholders.
• Ability to thrive in ambiguity and lead organizations through change.
• Strong analytical, problem-solving, and prioritization skills.

Travel Requirements

10-20% travel, primarily global.